24 September 2019
By Dr Wendy Winnall - PCFA Research Team
Prostate cancer drugs are big business. It’s not ideal that companies profit from illness, but there are advantages to this situation. A large market for prostate cancer medicine means that these companies invest considerable resources into developing new drugs. The news coming from this industry can therefore tell us about the potential future treatments for men with prostate cancer.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.